Distinct IgM and IgG autoantibody profiles characterize incomplete and classified systemic autoimmune diseases - Report - MDSpire

Distinct IgM and IgG autoantibody profiles characterize incomplete and classified systemic autoimmune diseases

  • By

  • Rebecca A. Wood

  • Neha Kodali

  • Nancy Redinger

  • A. Darise Farris

  • Christopher J. Lessard

  • R. Hal Scofield

  • June 17, 2026

  • 0 min

Share

Unique Profiles of IgM and IgG Autoantibodies Differentiate Autoimmune Disorders

Overview

This study identifies distinct IgM and IgG autoantibody profiles in incomplete lupus erythematosus (ILE) and non-Sjögren’s disease sicca (nSjD-sicca) compared to established autoimmune diseases like systemic lupus erythematosus (SLE) and Sjögren’s disease (SjD). The findings suggest that isotype-specific autoantibody profiling may enhance disease classification and understanding of autoimmune conditions.

Background

Autoimmune diseases affect millions and are characterized by the production of autoantibodies against self-antigens, leading to inflammation and diverse clinical manifestations. Incomplete forms of these diseases, such as ILE and nSjD-sicca, often present diagnostic challenges due to their heterogeneous nature and overlap with more established conditions. Understanding the immunologic differences between these states is crucial for accurate diagnosis and management.

Data Highlights

ConditionAutoantibodyPrevalence
ILEanti-nRNP26.3%
ILEanti-chromatin25.0%
SLEanti-SmRNP40.0%
SLEanti-dsDNA31.3%
nSjD-siccaanti-La9.6%
SjDanti-Ro/SSA53.3%

Key Findings

  • ILE shows significantly increased IgM autoreactivity compared to SLE.
  • Distinct IgM profiles in ILE target various antigens including nuclear and cytokine-related antigens.
  • SLE demonstrates enriched IgG responses to canonical nuclear antigens.
  • Ro52 IgG autoantibodies are significantly increased in SjD compared to nSjD-sicca.
  • Autoantibody profiles can aid in differentiating incomplete from established autoimmune diseases.

Clinical Implications

The identification of unique IgM and IgG autoantibody profiles can assist clinicians in distinguishing between incomplete and established autoimmune disorders, potentially guiding treatment decisions. Isotype-specific profiling may enhance diagnostic accuracy and inform monitoring strategies for patients with autoimmune conditions.

Conclusion

This study highlights the importance of autoantibody profiling in understanding autoimmune diseases, suggesting that distinct IgM and IgG responses may serve as valuable biomarkers for disease classification and management.

Related Resources & Content

  1. Sammaritano, L., Arthritis Care & Research, 2025 -- 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus
  2. British Society for Rheumatology, University of Birmingham -- British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
  3. Acta Neuropathologica — Patterns of Complement and MHC as a Diagnostic Framework for Inflammatory Neuromuscular Disorders
  4. International Journal of Infectious Diseases — Anti-interferon-γ autoantibody syndrome mimicking lymphoproliferative disorders: a case series
  5. Frontiers in Medicine — Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisons
  6. The Journal of Clinical Endocrinology & Metabolism — Comprehensive Evaluation and Network Visualization of Disease Links in Autoimmune Polyglandular Syndrome
  7. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus - Sammaritano - Arthritis Care & Research - Wiley Online Library
  8. British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease - University of Birmingham
  9. Full article: Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus

Original Source(s)

Related Content